Evidence map›Paper›PMID 26276745›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2015

Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model.

Sarah A Mazzilli, Pamela A Hershberger, Mary E Reid, Paul N Bogner, Kristopher Atwood, Donald L Trump, Candace S Johnson

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Impact of dietary vitamin D on initiation and progression of oral cancer.The Journal of steroid biochemistry and molecular biology · 2020
    Article
  6. Article
  7. A Festschrift in Honor of Edward M. Messing, MD, FACS.Bladder cancer (Amsterdam, Netherlands) · 2018
    Article
  8. Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sarah A MazzilliDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York. Mazzilli@bu.edu.
Pamela A HershbergerDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York.
Mary E ReidDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
Paul N BognerDepartment of Pathology, Roswell Park Cancer Institute, Buffalo, New York.
Kristopher AtwoodDepartment of Biostatistics, Roswell Park Cancer Institute, Buffalo New York.
Donald L TrumpInova Health System, Falls Church, Virginia.
Candace S JohnsonDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Vitamin D3 Modulation of Inflammation and Lung Cancer RiskP50CA090440 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DACIC, SANJA · 2001 to 2015
$34.6M
ANTITUMOR MECHANISMS &THERAPEUTIC EFFECTS OF VITAMIN DR01CA067267 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHNSON, CANDACE S, TRUMP, DONALD L · 1995 to 2013
$5.7M
DRUG DEVELOPMENT AND CANCER TREATMENTST32CA009072 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI JOHNSON, CANDACE S · 1985 to 2014
$2.3M
The effects of 1,25(OH)2D3 on the tumorigenesis of lung squamous cell carcinomaF31AT006487 · NCCIH · ROSWELL PARK CANCER INSTITUTE CORP · PI MAZZILLI, SARAH ANNE · 2011 to 2012
$55k
NCCIH NIH HHS F31AT0006487NCCIH NIH HHS F31 AT006487NCI NIH HHS CA067267NCI NIH HHS P30 CA016056NCI NIH HHS P30CA016056NCI NIH HHS P50 CA090440NCI NIH HHS R01 CA067267NCI NIH HHS T32 CA009072
6 · The paper itself

Abstract

The chemopreventive actions of vitamin D were examined in the N-nitroso-tris-chloroethylurea (NTCU) mouse model, a progressive model of lung squamous cell carcinoma (SCC). SWR/J mice were fed a deficient diet (D) containing no vitamin D3, a sufficient diet (S) containing 2,000 IU/kg vitamin D3, or the same diets in combination with the active metabolite of vitamin D, calcitriol (C; 80 μg/kg, weekly). The percentage (%) of the mucosal surface of large airways occupied by dysplastic lesions was determined in mice after treatment with a total dose of 15 or 25 μmol NTCU (N). After treatment with 15 μmol NTCU, the percentages of the surface of large airways containing high-grade dysplastic (HGD) lesions were vitamin D-deficient + NTCU (DN), 22.7% [P < 0.05 compared with vitamin D-sufficient +NTCU (SN)]; DN + C, 12.3%; SN, 8.7%; and SN + C, 6.6%. The extent of HGD increased with NTCU dose in the DN group. Proliferation, assessed by Ki-67 labeling, increased upon NTCU treatment. The highest Ki-67 labeling index was seen in the DN group. As compared with SN mice, DN mice exhibited a three-fold increase (P < 0.005) in circulating white blood cells (WBC), a 20% (P < 0.05) increase in IL6 levels, and a four-fold (P < 0.005) increase in WBC in bronchial lavages. Thus, vitamin D repletion reduces the progression of premalignant lesions, proliferation, and inflammation, and may thereby suppress development of lung SCC. Further investigations of the chemopreventive effects of vitamin D in lung SCC are warranted.

Indexed as

AnimalsAnticarcinogenic AgentsCarcinoma, Squamous CellCholecalciferolDietDisease Models, AnimalDisease ProgressionEnzyme-Linked Immunosorbent AssayImmunohistochemistryLung NeoplasmsMiceMultiplex Polymerase Chain ReactionPrecancerous ConditionsReal-Time Polymerase Chain ReactionVitamin D DeficiencyAnticarcinogenic AgentsCholecalciferol

Identifiers

PMID26276745
PMCPMC4664525
OpenAlexW2152326780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.